Fundz

Cambrian Bioworks raised $1.45M in seed funding led by the Irani family office to enhance their automated molecular diagnostics platforms and expand into international markets.

PRIVATEAug 28, 2024

Amount Raised

$1.45 Million

Round Type

Seed

BengaluruBiotechnologyHealth CareGeneticsHealth Diagnostics

Investors

Vaibhav HegdeIrani Family Office

Description

Cambrian Bioworks has secured $1.45 million in seed funding to accelerate the development of its automated molecular diagnostics platforms and expand its research and development efforts. The round was led by the Irani family office, with participation from the company's CEO, Vaibhav Hegde.

Quick answer

Cambrian Bioworks raised $1.45 Million in a Seed round, dated August 28, 2024. Investors: Vaibhav Hegde and Irani Family Office. Cambrian Bioworks is based in Bengaluru, Karnataka, India.

How much did Cambrian Bioworks raise?
Cambrian Bioworks raised $1.45 Million in a Seed round on August 28, 2024.
Who invested in Cambrian Bioworks?
Vaibhav Hegde and Irani Family Office are named as investors in this round.
What does Cambrian Bioworks do?
Cambrian Bioworks is a biotechnology company based in Bengaluru that focuses on solutions for next-generation sequencing (NGS) and molecular diagnostics.
Where is Cambrian Bioworks based and how big is it?
Cambrian Bioworks is based in Bengaluru, Karnataka, India. Fundz records about 30 employees.
Who are the decision-makers at Cambrian Bioworks?
Fundz holds 1 contact at Cambrian Bioworks. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Genetics and Health Diagnostics around the same time

Companies in the same sectors as Cambrian Bioworks that raised within 45 days of this round, from Fundz verified event records.

  • Insight Molecular Diagnostics Inc. raised $10M on October 2, 2024.
  • 4baseCare raised $6M (Series A) on August 12, 2024.
  • MONCYTE Health raised $1.1M (Seed) on October 8, 2024.
  • Syantra raised $3.9M (Series A) on September 11, 2024.
  • Viome raised $25M (Series D) on September 10, 2024.
  • Segmed raised $10M (Series A) on September 3, 2024.

Who to call at Cambrian Bioworks, and when

A new round usually means Cambrian Bioworks is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cambrian Bioworks raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cambrian Bioworks, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cambrian Bioworks. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cambrian Bioworks

Location

Bengaluru, Karnataka, India

About

Cambrian Bioworks is a biotechnology company based in Bengaluru that focuses on solutions for next-generation sequencing (NGS) and molecular diagnostics. Their technologies, such as the nucleic acid extraction platform Manta, aim to enhance cancer care through precise diagnosis and therapy selection. The company is committed to expanding its automated diagnostic platforms and R&D efforts. It seeks to improve access to automated devices for various genomic testing applications.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cambrian Bioworks raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Cambrian Bioworks's next move

See what Strategic adds

Cambrian Bioworks raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.